Skip to main content

Table 1 Characteristics of stroke patients according to stroke outcomes

From: The association between serum adiponectin and 3-month outcome after ischemic stroke

 

Total

Good outcomes

Poor outcomes

Pa

N

227

169

58

–

Age, years

64 (53–72)

62 (51–70)

71 (62–83)

0.009

Sex-male

128 (56.4)

94 (55.6)

34 (58.6)

0.69

BMI, kg/m2

24.2 (22.8–26.4)

24.0 (22.7–26.3)

24.5 (23.2–26.8)

0.38

Prior vascular risk factors, n (%)

 Hypertension

145 (63.9)

102 (60.4)

43 (74.1)

0.059

 Hypercholesterolemia

68 (30.0)

49 (29.0)

19 (32.8)

0.59

 Coronary heart disease

57 (25.1)

42 (24.9)

15 (25.9)

0.88

 Atrial fibrillation

49 (21.6)

31 (18.3)

18 (31.0)

0.043

 Diabetes mellitus

53 (23.3)

38 (22.5)

15 (25.9)

0.60

 Previous TIA

25 (11.0)

17 (10.1)

8 (13.8)

0.43

 Smoking

55 (24.2)

40 (23.7)

15 (25.9)

0.74

Pre-stroke treatment, n (%)

 Antihypertensive treatment

130 (57.3)

95 (56.2)

35 (60.3)

0.58

 Antidiabetic

31 (13.7)

23 (13.6)

8 (13.8)

0.97

 Antiplatelet agents

72 (31.7)

52 (30.8)

20 (34.5)

0.60

 Anticoagulants

23 (10.1)

18 (10.7)

5 (8.6)

0.66

 Statins

51 (22.5)

37 (21.9)

14 (24.1)

0.72

Acute treatment, n (%)

 IV thrombolysis

27 (11.9)

26 (15.4)

1 (1.7)

0.011

 Mechanical thrombectomy

17 (7.5)

16 (9.5)

1 (1.7)

0.053

Stroke etiology, n (%)

 Small-vessel occlusive

33 (14.5)

26 (15.4)

7 (12.1)

0.54

 Large-vessel occlusive

41 (18.1)

31 (18.3)

10 (17.2)

0.85

 Cardioembolic

75 (33.0)

56 (33.1)

19 (32.8)

0.96

 Other

15 (6.6)

11 (6.5)

4 (6.9)

0.92

 Unknown

63 (27.8)

45 (26.6)

18 (31.0)

0.52

Stroke severity, NIHSS at admission

6 (2–11)

5 (1–9)

9 (5–15)

< 0.001

DWI lesion, ml

15.2 (8.5–26.5)

13.2 (7.1–21.4)

20.9 (11.3–33.7)

< 0.001

Laboratory findings

 Glucose level, mmol/l

5.95 (5.53–6.63)

5.73 (5.35–6.33)

6.35 (5.94–7.15)

0.009

 CRP, mg/l

5.6 (3.0–9.2)

4.9 (2.5–7.9)

7.0 (4.7–11.7)

< 0.001

 Adiponectin, μg/ml

7.0 (4.4–10.0)

6.3 (4.0–8.9)

10.0 (7.0–13.9)

< 0.001

Stroke syndrome

 TACS

24 (10.6)

10 (5.9)

14 (24.1)

< 0.001

 PACS

96 (42.3)

72 (42.6)

24 (41.4)

0.87

 LACS

54 (23.8)

37 (21.9)

17 (29.3)

0.25

 POCS

53 (23.3)

50 (29.6)

3 (5.2)

< 0.001

  1. The results of categorical variable and continuous variable were presented as n (percentage) and median value (IQR). The mRS of 0–2 points was indicated as a good functional outcome, while 3–6 points was defined as poor outcome
  2. NIHSS National Institutes of Health Stroke Scale, TIA transient ischemic attack, IL-6 interleukin-6, IQR interquartile ranges, mRS modified Rankin Scale, DWI diffusion weighted imaging, TACS total anterior circulation syndrome, PACS partial anterior circulation syndrome, LACS lacunar syndrome, POCS posterior circulation syndrome, CRP C-reactive protein
  3. aChi-square and Mann–Whitney U test were applied for comparing the proportions and medians values between groups